Julianne Mercer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julianne Mercer has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Justina Lipscomb
College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA
3 shared publications Grace Lee
The University of Texas at Austin College of Pharmacy, Division of Pharmacotherapy and Translationsal Sciences, Austin, TX, USA; UT Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX, USA; South Texas Veterans Health Care System, Center for Personalized Medicine, USA
2 shared publications- Adriana Vargus
Department of Pharmacotherapy and Translational Science, College of Pharmacy, The University of Texas at Austin, San Antonio, USA
1 shared publication Alina Liang
1 shared publication- Benjamin A. Encino
College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA
1 shared publication Benjamin Encino
The University of Texas at Austin College of Pharmacy, Division of Pharmacotherapy and Translationsal Sciences, Austin, TX, USA; UT Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX, USA
1 shared publication
Latest Publications
- 18 May 2026
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (7) , 102004
Advancing Pharmacy Students’ Competence in Transgender Health: Multicohort Evaluation of a Gender-Affirming Therapy Curriculum
- 18 May 2026
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (7) , 102004
Advancing Pharmacy Students’ Competence in Transgender Health: Multicohort Evaluation of a Gender-Affirming Therapy Curriculum
- Open Access
- 29 August 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (9) , 2023
Pathoadapative Genomic Determinants of Staphylococcus aureus Community Skin Infections and Nasal Colonization
Staphylococcus aureus is a leading cause of skin and soft tissue infections (SSTIs), yet the bacterial genomic adaptations underlying the transition from nasal colonization to invasive infection remain incompletely defined. We sequenced and analyzed 157 S. aureus isolates (126 from SSTIs and 31 from asymptomatic nasal colonization) from a primary care network in South Texas. Using genome-wide association studies, non-synonymous single-nucleotide variant (NSNV) profiling, and machine learning, we identified strain-specific adaptations in metabolic and regulatory pathways. SSTI isolates exhibited significant enrichment of nitrogen assimilation, purine biosynthesis, menaquinone production, and anaerobic respiration genes. Elevated copy number and colocalization of phage-linked metabolic genes—including nirB, narH, and nifR3—suggest a pathoadaptive genomic island supporting infection-specific energy generation. The enrichment of α/β-hydrolase domain-encoding genes was associated with clinical severity. To quantify severity, we developed the Purulent Ulcer Skin (PUS) score, which integrates wound size, drainage, and erythema. The α/β-hydrolase and lipoprotein genes were significantly associated with higher PUS scores (higher SSTI severity) and phage-encoded virulence gene products were linked to larger wound size. Machine learning prioritized purL and other metabolic loci as key infection classifiers. NSNVs and unitig-level changes co-localized within nutrient transport, stress resistance, and cytolytic genes, supporting a model of multi-layered genomic selection. Metagenomic assemblies of nasal microbiota were enriched for Staphylococcus, Enterococcus, and Micrococcus species, core metabolic pathways, and taxon-specific virulence determinants. This underscores the roles of metabolic and virulent co-networks within nasal commensals and their adaptive capacity for pathogenic transition. These findings provide a potential genomic blueprint of S. aureus pathoadaptation during SSTI and are a step towards the development of novel therapeutic targets.
- 29 August 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (9) , 2023
Open AccessPathoadapative Genomic Determinants of Staphylococcus aureus Community Skin Infections and Nasal Colonization
Staphylococcus aureus is a leading cause of skin and soft tissue infections (SSTIs), yet the bacterial genomic adaptations underlying the transition from nasal colonization to invasive infection remain incompletely defined. We sequenced and analyzed 157 S. aureus isolates (126 from SSTIs and 31 from asymptomatic nasal colonization) from a primary care network in South Texas. Using genome-wide association studies, non-synonymous single-nucleotide variant (NSNV) profiling, and machine learning, we identified strain-specific adaptations in metabolic and regulatory pathways. SSTI isolates exhibited significant enrichment of nitrogen assimilation, purine biosynthesis, menaquinone production, and anaerobic respiration genes. Elevated copy number and colocalization of phage-linked metabolic genes—including nirB, narH, and nifR3—suggest a pathoadaptive genomic island supporting infection-specific energy generation. The enrichment of α/β-hydrolase domain-encoding genes was associated with clinical severity. To quantify severity, we developed the Purulent Ulcer Skin (PUS) score, which integrates wound size, drainage, and erythema. The α/β-hydrolase and lipoprotein genes were significantly associated with higher PUS scores (higher SSTI severity) and phage-encoded virulence gene products were linked to larger wound size. Machine learning prioritized purL and other metabolic loci as key infection classifiers. NSNVs and unitig-level changes co-localized within nutrient transport, stress resistance, and cytolytic genes, supporting a model of multi-layered genomic selection. Metagenomic assemblies of nasal microbiota were enriched for Staphylococcus, Enterococcus, and Micrococcus species, core metabolic pathways, and taxon-specific virulence determinants. This underscores the roles of metabolic and virulent co-networks within nasal commensals and their adaptive capacity for pathogenic transition. These findings provide a potential genomic blueprint of S. aureus pathoadaptation during SSTI and are a step towards the development of novel therapeutic targets.
- 8 November 2023
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 61 (12) , 1064-1065
Tirzepatide-associated starvation ketoacidosis
- 8 November 2023
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 61 (12) , 1064-1065
Tirzepatide-associated starvation ketoacidosis
- 22 August 2023
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (6) , 1669-1676.e1
Gender-affirming pharmacotherapy and additional health considerations: A contemporary review
- 22 August 2023
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (6) , 1669-1676.e1
Gender-affirming pharmacotherapy and additional health considerations: A contemporary review
- 6 January 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 62 (4) , 1172-1178.e3
COVID-19 pandemic vaccination preparedness strategies for independent community pharmacies
- 6 January 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 62 (4) , 1172-1178.e3
COVID-19 pandemic vaccination preparedness strategies for independent community pharmacies